Parkin-Knockout Mice did not Display Increased Vulnerability to Intranasal Administration of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Parkin-Knockout Mice did not Display Increased Vulnerability to Intranasal Administration of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Authors
Keywords
Parkinson’s disease, Parkin, MPTP, Intranasal, Neurodegeneration, Amphetamine
Journal
NEUROTOXICITY RESEARCH
Volume 24, Issue 2, Pages 280-287
Publisher
Springer Nature
Online
2013-04-16
DOI
10.1007/s12640-013-9389-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease
- (2012) Adalberto A. Castro et al. BEHAVIOURAL BRAIN RESEARCH
- Inactivation ofPink1Genein VivoSensitizes Dopamine-producing Neurons to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and Can Be Rescued by Autosomal Recessive Parkinson Disease Genes,ParkinorDJ-1
- (2012) M. Emdadul Haque et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies
- (2012) Erwan Bezard et al. MOVEMENT DISORDERS
- In Vivo Manganese Exposure Modulates Erk, Akt and Darpp-32 in the Striatum of Developing Rats, and Impairs Their Motor Function
- (2012) Fabiano M. Cordova et al. PLoS One
- The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinson's disease
- (2011) Rui D. S. Prediger et al. CURRENT PHARMACEUTICAL DESIGN
- Parkin-Mediated Protection of Dopaminergic Neurons in a Chronic MPTP-Minipump Mouse Model of Parkinson Disease
- (2011) Toru Yasuda et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Intranasal Administration of Neurotoxicants in Animals: Support for the Olfactory Vector Hypothesis of Parkinson’s Disease
- (2011) Rui D. S. Prediger et al. NEUROTOXICITY RESEARCH
- Lipopolysaccharide and Tumor Necrosis Factor Regulate Parkin Expression via Nuclear Factor-Kappa B
- (2011) Thi A. Tran et al. PLoS One
- Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson’s disease
- (2010) Eduardo L. G. Moreira et al. JOURNAL OF NEURAL TRANSMISSION
- A rotarod test for evaluation of motor skill learning
- (2010) Hiromi Shiotsuki et al. JOURNAL OF NEUROSCIENCE METHODS
- The PINK1/Parkin pathway: a mitochondrial quality control system?
- (2009) Alexander J. Whitworth et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
- (2009) Malú G. Tansey et al. NEUROBIOLOGY OF DISEASE
- Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease
- (2009) Rui D. S. Prediger et al. NEUROTOXICITY RESEARCH
- Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration
- (2008) T. C. Frank-Cannon et al. JOURNAL OF NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started